264 related articles for article (PubMed ID: 6314060)
1. Prognostic significance of N1 disease in carcinoma of the lung.
Martini N; Flehinger BJ; Nagasaki F; Hart B
J Thorac Cardiovasc Surg; 1983 Nov; 86(5):646-53. PubMed ID: 6314060
[TBL] [Abstract][Full Text] [Related]
2. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
Ferguson MK; Little AG; Golomb HM; Hoffman PC; DeMeester TR; Beveridge R; Skinner DB
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776
[TBL] [Abstract][Full Text] [Related]
3. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.
McCaughan BC; Martini N; Bains MS; McCormack PM
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):836-41. PubMed ID: 2987619
[TBL] [Abstract][Full Text] [Related]
4. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
6. Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.
Mitchell JD; Mathisen DJ; Wright CD; Wain JC; Donahue DM; Allan JS; Moncure AC; Grillo HC
J Thorac Cardiovasc Surg; 2001 Mar; 121(3):465-71. PubMed ID: 11241081
[TBL] [Abstract][Full Text] [Related]
7. Sleeve lobectomy for carcinoma of the lung.
Weisel RD; Cooper JD; Delarue NC; Theman TE; Todd TR; Pearson FG
J Thorac Cardiovasc Surg; 1979 Dec; 78(6):839-49. PubMed ID: 228125
[TBL] [Abstract][Full Text] [Related]
8. A contribution on the prognostic significance of the tumor formula (pTNM) in squamous cell carcinoma of the bronchus.
Huwer H; Volkmer I; Hülsewede R; Hausinger F
Thorac Cardiovasc Surg; 1989 Oct; 37(5):281-4. PubMed ID: 2588245
[TBL] [Abstract][Full Text] [Related]
9. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
11. Prognostic evaluation of tracheobronchial reconstruction for bronchogenic carcinoma.
Fujimura S; Kondo T; Imai T; Yamauchi A; Handa M; Okabe T; Nakada T
J Thorac Cardiovasc Surg; 1985 Aug; 90(2):161-6. PubMed ID: 2991667
[TBL] [Abstract][Full Text] [Related]
12. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
13. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
[TBL] [Abstract][Full Text] [Related]
14. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
17. Prognosis for resected lung cancer patients with tumors greater than ten centimeters in diameter.
Sano T; Naruke T; Kondo H; Goya T; Tsuchiya R; Suemasu K
Jpn J Clin Oncol; 1990 Dec; 20(4):369-73. PubMed ID: 2283720
[TBL] [Abstract][Full Text] [Related]
18. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
19. Bronchoplastic procedures and pulmonary artery reconstruction in the treatment of bronchogenic cancer.
Belli L; Meroni A; Rondinara G; Beati CA
J Thorac Cardiovasc Surg; 1985 Aug; 90(2):167-71. PubMed ID: 2991668
[TBL] [Abstract][Full Text] [Related]
20. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
